{"id":25726,"date":"2025-02-21T09:09:20","date_gmt":"2025-02-21T08:09:20","guid":{"rendered":"https:\/\/idibell.cat\/es\/?p=25726"},"modified":"2025-02-21T09:10:09","modified_gmt":"2025-02-21T08:10:09","slug":"el-idibell-recibe-financiacion-para-cuatro-proyectos-de-investigacion-con-consorcio-internacional","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2025\/02\/el-idibell-recibe-financiacion-para-cuatro-proyectos-de-investigacion-con-consorcio-internacional\/","title":{"rendered":"El IDIBELL recibe financiaci\u00f3n para cuatro proyectos de investigaci\u00f3n con consorcio internacional"},"content":{"rendered":"<p><span data-contrast=\"auto\">Las <\/span><b><span data-contrast=\"auto\">ERA-NETs<\/span><\/b><span data-contrast=\"auto\"> (European Research Areas) son una red de colaboraci\u00f3n europea entre diferentes organismos o agencias p\u00fablicas que se dedican a financiar la investigaci\u00f3n de diferentes pa\u00edses del continente. A trav\u00e9s de ellas, se busca fomentar la colaboraci\u00f3n y coordinaci\u00f3n multinacional entre investigadores para facilitar el intercambio de conocimientos y recursos y poder ser m\u00e1s ambiciosos. As\u00ed, se consigue dar oportunidades a la internacionalizaci\u00f3n de una investigaci\u00f3n de mayor impacto, y apuntar hacia la creaci\u00f3n de espacios de investigaci\u00f3n m\u00e1s integrados y cohesionados dentro de Europa.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559740&quot;:278}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">En el marco de este programa, cuatro proyectos del Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL), tres de medicina personalizada y uno de medicina traslacional, han recibido la financiaci\u00f3n de diferentes entidades nacionales. El importe total ha ascendido a 709.689\u20ac, y los proyectos se iniciar\u00e1n, a nivel internacional, en breve. Las l\u00edneas de investigaci\u00f3n que se benefician son las siguientes:\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:240,&quot;335559740&quot;:278}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\u00b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\u00b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">&#8220;Advancing Personalised Medicine for Anorexia Nervosa: A companion Biomarker-Target Approach&#8221; (<\/span><b><span data-contrast=\"auto\">BIOREXIA<\/span><\/b><span data-contrast=\"auto\">), del <\/span><b><span data-contrast=\"auto\">Dr. Fernando Fern\u00e1ndez Aranda<\/span><\/b><span data-contrast=\"auto\">, co-jefe del <\/span><a href=\"https:\/\/idibell.cat\/es\/investigacion\/area-de-neurociencias\/programa-de-neurociencias\/psiconeurobiologia-de-los-trastornos-de-la-conducta-alimentaria-y-conductas-adictivas\/\"><span data-contrast=\"none\">grupo de Psiconeurobiolog\u00eda de los trastornos alimentarios y conductas adictivas<\/span><\/a><span data-contrast=\"auto\"> de IDIBELL y director de la Unidad de Trastornos de la Conducta Alimentaria (TCA) del Servicio de Psicolog\u00eda del Hospital Universitario de Bellvitge (HUB).\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0,&quot;335559740&quot;:278}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\u00b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\u00b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">&#8220;Setting up and validating improved strategies for the identification and erradication of the poor prognosis fetal-type colorectal tumors&#8221; (<\/span><b><span data-contrast=\"auto\">COLOSTEM-APPLY<\/span><\/b><span data-contrast=\"auto\">), del <\/span><b><span data-contrast=\"auto\">Dr. Alberto Villanueva<\/span><\/b><span data-contrast=\"auto\">, co-jefe del <\/span><a href=\"https:\/\/idibell.cat\/es\/investigacion\/area-de-cancer\/programa-de-mecanismos-moleculares-y-terapia-experimental-en-oncologia-oncobell\/quimioresistencia-tumoral-y-estromal\/\"><span data-contrast=\"none\">grupo de Quimioresistencia tumoral y estromal<\/span><\/a><span data-contrast=\"auto\"> del IDIBELL e investigador del programa ProCURE del Instituto Catal\u00e1n de Oncolog\u00eda (ICO).\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0,&quot;335559740&quot;:278}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\u00b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\u00b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">&#8220;A NANO-theranostic tool TO prevent mechanosensing-dependiente pro-fibrotic evolution and failure of the HEART&#8221; (<\/span><b><span data-contrast=\"auto\">Nano-to-Heart<\/span><\/b><span data-contrast=\"auto\">), del <\/span><b><span data-contrast=\"auto\">Dr. Angel Raya<\/span><\/b><span data-contrast=\"auto\">, coordinador del programa <\/span><a href=\"https:\/\/idibell.cat\/es\/investigacion\/area-medicina-regenerativa-es\/programa-de-medicina-regenerativa\/\"><span data-contrast=\"none\">Regenbell<\/span><\/a><span data-contrast=\"auto\"> y jefe del <\/span><a href=\"https:\/\/idibell.cat\/es\/investigacion\/area-medicina-regenerativa-es\/programa-de-medicina-regenerativa\/potencia-de-celulas-madre\/\"><span data-contrast=\"none\">grupo de investigaci\u00f3n en Potencia de c\u00e9lulas madre<\/span><\/a><span data-contrast=\"auto\"> de IDIBELL.\u00a0<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0,&quot;335559740&quot;:278}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li data-leveltext=\"\u00b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\u00b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"auto\">&#8220;Inclusive Healthcare Access and Personalized Health Management for Children and Adolescents&#8221; (<\/span><b><span data-contrast=\"auto\">CONNECT-CARE<\/span><\/b><span data-contrast=\"auto\">), con la participaci\u00f3n del <\/span><b><span data-contrast=\"auto\">Dr. Fernando Fern\u00e1ndez Aranda<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0,&quot;335559740&quot;:278}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><i><span data-contrast=\"auto\">El Instituto de Investigaci\u00f3n Biom\u00e9dica de Bellvitge (IDIBELL) es un centro de investigaci\u00f3n en biomedicina creado en 2004. Est\u00e1 participado por el Hospital Universitario de Bellvitge y el Hospital de Viladecans del Instituto Catal\u00e1n de la Salud, el Instituto Catal\u00e1n de Oncolog\u00eda, la Universidad de Barcelona y el Ayuntamiento de L&#8217;Hospitalet de Llobregat.<\/span><\/i><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n<p><i><span data-contrast=\"auto\">El IDIBELL es miembro del Campus de Excelencia Internacional de la Universidad de Barcelona HUBc y forma parte de la instituci\u00f3n CERCA de la Generalitat de Catalunya. En 2009 se convirti\u00f3 en uno de los cinco primeros centros de investigaci\u00f3n espa\u00f1oles acreditados como instituto de investigaci\u00f3n sanitaria por el Instituto de Salud Carlos III. Adem\u00e1s, forma parte del programa &#8220;HR Excellence in Research&#8221; de la Uni\u00f3n Europea y es miembro de EATRIS y REGIC. Desde el a\u00f1o 2018, IDIBELL es un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/span><\/i><span data-ccp-props=\"{&quot;335551550&quot;:6,&quot;335551620&quot;:6}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Se han recibido un total de 709.689\u20ac, y los proyectos iniciar\u00e1n en breve a nivel internacional<\/p>\n","protected":false},"author":8,"featured_media":25727,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-25726","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"publishpress_future_action":{"enabled":false,"date":"2025-03-01 11:34:31","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/25726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=25726"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/25726\/revisions"}],"predecessor-version":[{"id":25728,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/25726\/revisions\/25728"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/25727"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=25726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=25726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=25726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}